MedTrace Logo

Impact of Systemic Manifestations/Comorbidities on Clinical State, Prognosis, Utilisation of Health Care Resources in Patients With COPD

NCT01245933 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2741

Last updated 2024-04-12

No results posted yet for this study

Summary

The purpose of this study is to determine the prevalence and severity of extrapulmonary disorders and to quantify the impact of extrapulmonary organ manifestations on morbidity and mortality of COPD patients.

Furthermore the investigators evaluate the relationship between systemic inflammation and organ involvement.

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Sponsors & Collaborators

  • Hannover Medical School

    collaborator OTHER

  • Ludwig-Maximilians - University of Munich

    collaborator OTHER

  • Philipps University Marburg

    lead OTHER

Principal Investigators

  • Claus Vogelmeier, Prof. · Philipps University Marburg

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2013-12-31
Completion
2023-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01245933 on ClinicalTrials.gov